ERBB2 and breast cancer: The presented data demonstrate efficient ErbB3 targeting by the single-domain antibody in breast cancer cell cultures, and visualize the existence of isolated clusters of “oncogenic units” [6], where signaling through ErbB2/ErbB3 heterodimers does occur.